logo
logo
twitter facebook facebook
Bright Minds Biosciences
Bright Minds Biosciences focuses on creating the next generation of psychedelics to treat mental health disorders.
twitter facebook facebook
Toronto, Ontario http://brightmindsbio.com/
Followers 2 Following 1
Bright Minds Biosciences 22h
img
Bright Minds Biosciences is a biotechnology company that specializes in neuropsychiatry and drug development, which targets neuropsychiatric disorders, pain, and epilepsy. Their serotonergic drugs can help various syndromes associated with epilepsy.
collect
1
Bright Minds Biosciences 2021-11-24
img
The mainstream society wasn’t very accepting of psychedelics before they were involved more in medical instead of recreational use of psychedelics. While the major focus is on the medical use of them, there is always a chance that the market gets inclined in the other direction. We see that the cannabis market is highly evolving, and the chances are that the streams of making money may be better than the medical one.
collect
0
Bright Minds Biosciences 2021-11-10
img

Many of the investors who have not invested in the psychedelic company stocks are quite wary of the governance as well as the management issues.

They are also holding the belief that access to the capital might be strained as long the psychedelics do not get approval from the regulatory agencies.

The ultimate cost for the development of the next generation psychedelic inspired therapy is quite expensive.

collect
0
Bright Minds Biosciences 2021-10-28
img

The biotech sector has been generating many life-saving pharmaceuticals that take advantage of human genetics to deliver personalized treatments for every ailment or type of patient for several years now.

As more and more businesses obtain FDA approval, the industry is undergoing significant transformation.

Within a few years, the sector with Biotechnology Company is estimated to be worth hundreds of billions of dollars worldwide.

collect
0
Bright Minds Biosciences 2021-11-30
img
Mobile technologies have made it possible for patients to enjoy the convergence of software and health care through various convenient apps. This new technology is helping in transforming healthcare in a significant way and often in delivering advanced clinical outcomes. Bright Minds Biosciences is a biotechnology company that focuses on contributing to the health care industry.
collect
0
Bright Minds Biosciences 2021-11-17
img
The psychedelic companies are looking at a great future, but they cannot have large revenues to thrive until after legalization. Sooner or later, the psychedelic companies will be legalized, and there’s no doubt about that, but until then, the companies are operating under the hope of legalization, which is not a great position to exist in. Stock Market And InvestmentRecently, many psychedelic companies are making their debut in the stock market, and investments have been contributing to the advancements of their ongoing research and drug trials. Because investors, too, are making decisions on companies’ promises or positive regulation, one of which is not in control of the companies. Selling Functional MushroomsThere are companies that are exclusively working on selling functional mushrooms, but psychedelic companies are research-driven.
collect
0
Bright Minds Biosciences 2021-11-09
img

The research and development in the psychedelic front are advancing, owing to the potential of being the efficient mental health care treatment, evolving legislation and regulations along with the support of the public opinion.

Owing to all such factors, Bright Minds Bio company is looking forward to raising funds by listing its stocks on the Canadian Stock Exchange.

The investors are turning towards the psychedelic company stocks Canada that provides realistic and alternative therapies for mental illnesses.

collect
0
Bright Minds Biosciences 2021-10-27
img

Canada’s growing reputation as a world leader in medical and recreational cannabis research has now spilled over into psychedelics.

Because of Canada’s lax regulatory environment, researchers from around the world are flocking to our country to study how psychedelic compounds like LSD, psilocybin (the compound found in magic mushrooms), and MDMA (commonly known as ecstasy) can be used to treat mental health disorders such as depression and anxiety.

collect
0
Bright Minds Biosciences 2021-11-29
img
Canada has been at the forefront of developing psychedelics into something that helps treat mental health issues. While our society has not always supported psychedelics, it is now interesting to see how psychedelics are on the verge of transforming mental health treatment. Mind Medicine is another psychedelic company focused on developing psychedelic-inspired therapies and now is partnering with Sphere Health. Sphere Health is a pharmaceutical manufacturer that provides treatments for severe mental illness.
collect
0
Bright Minds Biosciences 2021-11-16
img
As far as the emerging industry is concerned, the psychedelic industry is one of them. There are many great players in the industry, including Mind Medicine, Compass Pathways, Numinus Wellness, Revive Therapeutics Ltd. , etc. , all of which have been providing new opportunities to the investors. Although investing in psychedelic company stocks is no different from any other stocks, but knowing the industry better will yield better results.
collect
0
Bright Minds Biosciences 2021-11-08
img

Every once in a while, there’s news that breaks our entrenched view of what is possible.

Recently, biotechnology company Bright Minds Bio announced that they are investing in psychedelic drugs to bring about positive effects in people with psychiatric disorders.

As per the experts, this drug offers hope not only to those suffering from depression and anxiety but also to all those who want an enhanced experience.

collect
0
Bright Minds Biosciences 2021-10-26
img

ATAI Life Sciences joined the mental health market in 2018 but is already working on various compounds for depression, anxiety, addiction, etc.

Their research is based on psychedelics, but they are now also involved in the digital health space.

IntroSpect is a digital platform of ATAI Life Sciences where they leverage flexibility and technology to meet their patient’s requirements.

collect
0
Bright Minds Biosciences 2021-11-25
img
Bright Minds Bio is a biotechnology company, with several neuroscientists working on serotonin agonists, potentially controlling seizures in neurons. Their pipeline of 5-HT2C agonists is unique and going through trials and evaluation for the treatment of epilepsy. Apart from epilepsy, serotonin (5-HT) receptors regulate cognitive functions, emotions, the sleep-wake cycle, and memories.
collect
0
Bright Minds Biosciences 2021-11-11
img

As the name suggests, Psychedelic drugs are all about changing the psychological perception of anyone who consumes it.

People also call them the hallucination-inducing medicines that they use to heighten their experience, which can be pleasure or peace.

Usually, people smoke psychedelic drugs, and the practice dates back to the early '20s.

Today psychedelic drugs also come in the form of tablets.

collect
0
Bright Minds Biosciences 2021-11-01
img

The 2020 pandemic has already exacerbated the mental health care crisis worldwide.

From the past two decades, the cases of drug overdose deaths along with the rates of suicides have already steeped to an extremely high rate.

All such trends are serving as a deep reflection of the flaws that are existing in the mental health care system.

collect
0
Bright Minds Biosciences 2021-10-25
img

Are you new to psychedelic stocks?

Many Canadian psychedelic companies are starting to establish a significant place in the pharmaceutical industry and will be major players in the next coming years.

Let’s see what these psychedelic company stocks Canada are and what they are up to in 2021.

Bright Minds Biosciences is a biotech company that focuses on serotonin-based medicines for mental health issues and epilepsy.

collect
0
Bright Minds Biosciences 22h
img
Bright Minds Biosciences is a biotechnology company that specializes in neuropsychiatry and drug development, which targets neuropsychiatric disorders, pain, and epilepsy. Their serotonergic drugs can help various syndromes associated with epilepsy.
Bright Minds Biosciences 2021-11-29
img
Canada has been at the forefront of developing psychedelics into something that helps treat mental health issues. While our society has not always supported psychedelics, it is now interesting to see how psychedelics are on the verge of transforming mental health treatment. Mind Medicine is another psychedelic company focused on developing psychedelic-inspired therapies and now is partnering with Sphere Health. Sphere Health is a pharmaceutical manufacturer that provides treatments for severe mental illness.
Bright Minds Biosciences 2021-11-24
img
The mainstream society wasn’t very accepting of psychedelics before they were involved more in medical instead of recreational use of psychedelics. While the major focus is on the medical use of them, there is always a chance that the market gets inclined in the other direction. We see that the cannabis market is highly evolving, and the chances are that the streams of making money may be better than the medical one.
Bright Minds Biosciences 2021-11-16
img
As far as the emerging industry is concerned, the psychedelic industry is one of them. There are many great players in the industry, including Mind Medicine, Compass Pathways, Numinus Wellness, Revive Therapeutics Ltd. , etc. , all of which have been providing new opportunities to the investors. Although investing in psychedelic company stocks is no different from any other stocks, but knowing the industry better will yield better results.
Bright Minds Biosciences 2021-11-10
img

Many of the investors who have not invested in the psychedelic company stocks are quite wary of the governance as well as the management issues.

They are also holding the belief that access to the capital might be strained as long the psychedelics do not get approval from the regulatory agencies.

The ultimate cost for the development of the next generation psychedelic inspired therapy is quite expensive.

Bright Minds Biosciences 2021-11-08
img

Every once in a while, there’s news that breaks our entrenched view of what is possible.

Recently, biotechnology company Bright Minds Bio announced that they are investing in psychedelic drugs to bring about positive effects in people with psychiatric disorders.

As per the experts, this drug offers hope not only to those suffering from depression and anxiety but also to all those who want an enhanced experience.

Bright Minds Biosciences 2021-10-28
img

The biotech sector has been generating many life-saving pharmaceuticals that take advantage of human genetics to deliver personalized treatments for every ailment or type of patient for several years now.

As more and more businesses obtain FDA approval, the industry is undergoing significant transformation.

Within a few years, the sector with Biotechnology Company is estimated to be worth hundreds of billions of dollars worldwide.

Bright Minds Biosciences 2021-10-26
img

ATAI Life Sciences joined the mental health market in 2018 but is already working on various compounds for depression, anxiety, addiction, etc.

Their research is based on psychedelics, but they are now also involved in the digital health space.

IntroSpect is a digital platform of ATAI Life Sciences where they leverage flexibility and technology to meet their patient’s requirements.

Bright Minds Biosciences 2021-11-30
img
Mobile technologies have made it possible for patients to enjoy the convergence of software and health care through various convenient apps. This new technology is helping in transforming healthcare in a significant way and often in delivering advanced clinical outcomes. Bright Minds Biosciences is a biotechnology company that focuses on contributing to the health care industry.
Bright Minds Biosciences 2021-11-25
img
Bright Minds Bio is a biotechnology company, with several neuroscientists working on serotonin agonists, potentially controlling seizures in neurons. Their pipeline of 5-HT2C agonists is unique and going through trials and evaluation for the treatment of epilepsy. Apart from epilepsy, serotonin (5-HT) receptors regulate cognitive functions, emotions, the sleep-wake cycle, and memories.
Bright Minds Biosciences 2021-11-17
img
The psychedelic companies are looking at a great future, but they cannot have large revenues to thrive until after legalization. Sooner or later, the psychedelic companies will be legalized, and there’s no doubt about that, but until then, the companies are operating under the hope of legalization, which is not a great position to exist in. Stock Market And InvestmentRecently, many psychedelic companies are making their debut in the stock market, and investments have been contributing to the advancements of their ongoing research and drug trials. Because investors, too, are making decisions on companies’ promises or positive regulation, one of which is not in control of the companies. Selling Functional MushroomsThere are companies that are exclusively working on selling functional mushrooms, but psychedelic companies are research-driven.
Bright Minds Biosciences 2021-11-11
img

As the name suggests, Psychedelic drugs are all about changing the psychological perception of anyone who consumes it.

People also call them the hallucination-inducing medicines that they use to heighten their experience, which can be pleasure or peace.

Usually, people smoke psychedelic drugs, and the practice dates back to the early '20s.

Today psychedelic drugs also come in the form of tablets.

Bright Minds Biosciences 2021-11-09
img

The research and development in the psychedelic front are advancing, owing to the potential of being the efficient mental health care treatment, evolving legislation and regulations along with the support of the public opinion.

Owing to all such factors, Bright Minds Bio company is looking forward to raising funds by listing its stocks on the Canadian Stock Exchange.

The investors are turning towards the psychedelic company stocks Canada that provides realistic and alternative therapies for mental illnesses.

Bright Minds Biosciences 2021-11-01
img

The 2020 pandemic has already exacerbated the mental health care crisis worldwide.

From the past two decades, the cases of drug overdose deaths along with the rates of suicides have already steeped to an extremely high rate.

All such trends are serving as a deep reflection of the flaws that are existing in the mental health care system.

Bright Minds Biosciences 2021-10-27
img

Canada’s growing reputation as a world leader in medical and recreational cannabis research has now spilled over into psychedelics.

Because of Canada’s lax regulatory environment, researchers from around the world are flocking to our country to study how psychedelic compounds like LSD, psilocybin (the compound found in magic mushrooms), and MDMA (commonly known as ecstasy) can be used to treat mental health disorders such as depression and anxiety.

Bright Minds Biosciences 2021-10-25
img

Are you new to psychedelic stocks?

Many Canadian psychedelic companies are starting to establish a significant place in the pharmaceutical industry and will be major players in the next coming years.

Let’s see what these psychedelic company stocks Canada are and what they are up to in 2021.

Bright Minds Biosciences is a biotech company that focuses on serotonin-based medicines for mental health issues and epilepsy.